Applied StemCell

Milpitas, United States Founded: 2008 • Age: 18 yrs Acquired By QHP Capital
Provider of animal and cell line models as tools for drug discovery and diagnostics
Request Access

About Applied StemCell

Applied StemCell is a company based in Milpitas (United States) founded in 2008 was acquired by QHP Capital in October 2023.. Applied StemCell has raised $67.52 million across 10 funding rounds from investors including Fosun, HHS and Advantech Capital. The company has 53 employees as of December 31, 2022. Applied StemCell operates in a competitive market with competitors including Biocytogen, GenOway, Interius Biotherapeutics, Champion Oncology and GemPharmatech, among others.

  • Headquarter Milpitas, United States
  • Employees 53 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Applied Stemcell
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $67.52 M (USD)

    in 10 rounds

  • Latest Funding Round
    $1.98 M (USD), Grant

    Feb 01, 2020

  • Investors
    Fosun

    & 9 more

  • Employee Count
    53

    as on Dec 31, 2022

  • Acquired by
    QHP Capital

    (Oct 09, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Applied StemCell
Headcount 50-200
Employee Profiles 23
Board Members and Advisors 12
Employee Profiles
People
Karen D.
R&D Research Associate
People
Lucy Gu
Senior Director, Finance & Administration
People
Alfonso Farruggio
Head of Research & Development
People
Ruby Yanru Chen-Tsai
CEO and President

Unlock access to complete

Board Members and Advisors
people
Jun Hou
Board Member
people
Dean Tsao
Advisor
people
Michael Cleary
Advisor
people
Mark A. Kay
Advisor

Unlock access to complete

Funding Insights of Applied StemCell

Applied StemCell has successfully raised a total of $67.52M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $1.98 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 10
  • Last Round Grant — $2.0M
  • First Round
  • Investors Count 9
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2020 Amount Grant - Applied StemCell Valuation

investors

HHS
Jul, 2018 Amount Series D - Applied StemCell Valuation Fosun , Advantech Capital
Oct, 2016 Amount Series D - Applied StemCell Valuation Hermed Capital
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Applied StemCell

Applied StemCell has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Fosun, HHS and Advantech Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
PE firm focused on medicine based companies
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Applied StemCell

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Applied StemCell

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Applied Stemcell Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Applied StemCell

Applied StemCell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, GenOway, Interius Biotherapeutics, Champion Oncology and GemPharmatech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Integrated solutions for next-generation antibody drug development are provided.
domain founded_year HQ Location
Provider of transgenic rodent models and customized cell lines for preclinical development
domain founded_year HQ Location
Developer of gene therapies for treating multiple diseases
domain founded_year HQ Location
Drug response assays are performed using murine in vivo models.
domain founded_year HQ Location
Humanized models and drug screening technologies are developed for research.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Applied Stemcell

Frequently Asked Questions about Applied StemCell

When was Applied StemCell founded?

Applied StemCell was founded in 2008 and raised its 1st funding round 2 years after it was founded.

Where is Applied StemCell located?

Applied StemCell is headquartered in Milpitas, United States. It is registered at Milpitas, California, United States.

Is Applied StemCell a funded company?

Applied StemCell is a funded company, having raised a total of $67.52M across 10 funding rounds to date. The company's 1st funding round was a Series D of $19M, raised on Mar 18, 2010.

How many employees does Applied StemCell have?

As of Dec 31, 2022, the latest employee count at Applied StemCell is 53.

What does Applied StemCell do?

Provider of animal and cell line models as tools for drug discovery and diagnostics. Using its proprietary TARGATT gene modification technology, it makes site-specific Knockin mouse, rat, and human cell line models fast and efficient for the pharmaceutical and academic community. It focuses on the development and commercialization of mouse models, rat models, human cell line models, stem cell culture products, gene engineering in stem cells or other mammalian cells.

Who are the top competitors of Applied StemCell?

Applied StemCell's top competitors include Biocytogen, GenOway and Champion Oncology.

Who are Applied StemCell's investors?

Applied StemCell has 10 investors. Key investors include Fosun, HHS, Advantech Capital, Yuan Ming Capital, and Coalescence Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available